Pipecuronium (bromide)

CAT:
804-HY-B0743A-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Pipecuronium (bromide) - image 1

Pipecuronium (bromide)

  • Description :

    Pipecuronium bromide is a potent long-acting nondepolarizing steroidal neuromuscular blocking agent (NMBA), and a bisquaternary ammonium compound. Pipecuronium bromide is a powerful competitive nAChR antagonist with a Kd of 3.06 μM[1][2][3][4][5].
  • UNSPSC :

    12352005
  • Hazard Statement :

    H300, H312, H331
  • Target :

    NAChR
  • Type :

    Reference compound
  • Related Pathways :

    Membrane Transporter/Ion Channel; Neuronal Signaling
  • Applications :

    Neuroscience-Neuromodulation
  • Field of Research :

    Neurological Disease
  • Assay Protocol :

    https://www.medchemexpress.com/pipecuronium-bromide.html
  • Purity :

    99.88
  • Solubility :

    DMSO : 150 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
  • Smiles :

    C[C@@]1([C@H]2OC(C)=O)[C@](C[C@@H]2N3CC[N+](C)(C)CC3)([H])[C@@](CC[C@]4([H])[C@@]5(C[C@H](N6CC[N+](C)(C)CC6)[C@@H](OC(C)=O)C4)C)([H])[C@]5([H])CC1.[Br-].[Br-]
  • Molecular Formula :

    C35H62Br2N4O4
  • Molecular Weight :

    762.70
  • Precautions :

    H300, H312, H331
  • References & Citations :

    [1]Tassonyi E, et al. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial. Anesth Analg. 2015 Aug;121 (2) :373-80.|[2]Tassonyi E, et al. Reversal of Deep Pipecuronium-Induced Neuromuscular Block With Moderate Versus Standard Dose of Sugammadex: A Randomized, Double-Blind, Noninferiority Trial. Anesth Analg. 2018 Dec;127 (6) :1344-1350.|[3]Alánt O, et al. First clinical experience with a new neuromuscular blocker pipecurium bromide. Arzneimittelforschung. 1980;30 (2a) :374-9.|[4]Töröcsik A, et al. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur J Pharmacol. 1991 Sep 24;202 (3) :297-302.|[5]Kárpáti E, et al. Investigation of neuromuscular blocking agents at Richter Ltd. Acta Pharm Hung. 2002;72 (1) :37-48.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    4°C (Powder, sealed storage, away from moisture)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Launched
  • CAS Number :

    [52212-02-9]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide